Gapping down
In reaction to strong earnings/guidance:
- SFS -10.3%, BNFT -8.5%, JILL -8.1%, TACO -6%, CTRP -5.1%, WOW -2%, BITA -1.3%, GCO -1.2%
Other news:
- SLDB -57.4% (receives notification from the FDA that IGNITE DMD, its Phase I/II clinical trial for SGT-001 microdystrophin gene transfer in Duchenne muscular dystrophy, has been placed on Clinical Hold)
- SPEX -17.1% (proposes registered public offering of common stock on a 'best efforts' basis)
- IVTY -16.3% (to offer and sell shares of its common stock in an underwritten public offering)
- ABM -5% (to offer 9,047,741 shares of ABM common stock in an underwritten secondary offering by selling shareholders)
- AQUA -2.2% (prices 17.5 mln share secondary offering by holders at $22/share)
- VNDA -1.3% (to offer and sell shares of its common stock in an underwritten public offering;)
Analyst comments:
- MELI -4.1% (downgraded to Hold from Buy at Stifel)
- EXPE -1.9% (downgraded to Neutral from Outperform at Macquarie)